BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 1, 2002
View Archived Issues
Zonagen's Search For Merger Partner Ends With Lavipharm
Zonagen Inc., searching for ways to benefit shareholders for some time, said it is merging with Lavipharm Corp. in a move that should please Zonagen stockholders and fulfill Lavipharm's desire to become a public company. (BioWorld Today)
Read More
Embryo Joins Ranks Of Human Subjects Requiring Protection
Read More
A Newly Discovered Bacterium Lays Low Trichloroethane, A Worldwide Industrial Pollutant
Read More
SuperGen Plans Orathecin NDA Following Consultation With FDA
Read More
Cerus Gets $50M Loan Pledge From Intercept Partner Baxter
Read More
Other News To Note
Read More